- Home
- NIO vs CORT Comparison
NIO vs CORT Comparison
Compare NIO & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIO
- CORT
- Stock Information
- Founded
- NIO 2014
- CORT 1998
- Country
- NIO China
- CORT United States
- Employees
- NIO N/A
- CORT N/A
- Industry
- NIO Auto Manufacturing
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- NIO Consumer Discretionary
- CORT Health Care
- Exchange
- NIO Nasdaq
- CORT Nasdaq
- Market Cap
- NIO 7.4B
- CORT 7.1B
- IPO Year
- NIO 2018
- CORT N/A
- Fundamental
- Price
- NIO $4.09
- CORT $75.08
- Analyst Decision
- NIO Hold
- CORT Strong Buy
- Analyst Count
- NIO 6
- CORT 4
- Target Price
- NIO $5.05
- CORT $142.00
- AVG Volume (30 Days)
- NIO 35.1M
- CORT 1.3M
- Earning Date
- NIO 06-05-2025
- CORT 05-05-2025
- Dividend Yield
- NIO N/A
- CORT N/A
- EPS Growth
- NIO N/A
- CORT 8.36
- EPS
- NIO N/A
- CORT 1.14
- Revenue
- NIO $9,005,433,398.00
- CORT $685,446,000.00
- Revenue This Year
- NIO $37.90
- CORT $35.85
- Revenue Next Year
- NIO $26.13
- CORT $35.22
- P/E Ratio
- NIO N/A
- CORT $65.80
- Revenue Growth
- NIO 18.18
- CORT 30.93
- 52 Week Low
- NIO $3.02
- CORT $25.35
- 52 Week High
- NIO $7.71
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- NIO 53.31
- CORT 57.68
- Support Level
- NIO $3.96
- CORT $68.86
- Resistance Level
- NIO $4.22
- CORT $73.36
- Average True Range (ATR)
- NIO 0.13
- CORT 3.26
- MACD
- NIO 0.02
- CORT 0.12
- Stochastic Oscillator
- NIO 43.76
- CORT 95.28
About NIO NIO Inc. American depositary shares each representing one ordinary share
Nio is a leading electric vehicle maker, targeting the premium segment. Founded in November 2014, Nio designs, develops, jointly manufactures, and sells premium smart electric vehicles. The company differentiates itself through continuous technological breakthroughs and innovations such as battery swapping and autonomous driving technologies. Nio launched its first model, its ES8 seven-seater electric SUV, in December 2017, and began deliveries in June 2018. Its current model portfolio includes midsize to large sedans and SUVs. It sold around 222,000 EVs in 2024, accounting for about 2% of the China passenger new energy vehicle market.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.